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Breastfeeding-Associated	Neonatal	Hyperbilirubinemia	
Sara	McGaughey	Lord,	BSN,	RN,	RN-NIC
What	is	breastfeeding-associated	
hyperbilirubinemia?
References
Neonatal	jaundice	is	one	of	 the	most	common	 conditions	 in	
neonates,	with	60-80%	of	infants	experiencing	 some	degree	
of	 increased	serum	bilirubin	levels	(Itoh,	Okada,	Kuboi,	&	
Kusaka,	2017).		Physiological	jaundice	is	most	commonly	
noted	in	the	first	week	of	life,	with	rising	and	peak	levels	
occur	 between	day	of	life	three	to	five	(Moncrieff,	2018)		All	
infants	experience	 a	rise	in	serum	bilirubin	following	birth	
due	to	their	immature	liver’s	inability	to	clear	the	byproduct	
of	 red	blood	cell	breakdown,	bilirubin,	from	the	blood	
(Gardner,	Carter,	Hines,	&	Hernandez,	2016).	
Hyperbilirubinemia	can	be	caused	 by	a	variety	of	factors	
including,	 but	not	limited	to,	infection,	breast	feeding,	
hemolytic	disease	of	 the	newborn,	maternal-fetal	blood	type	
incompatibility,	drugs,	gestational	diabetes,	birth	trauma,	
prematurity,	hypothyroidism,	and	galactosemia.		The	most	
commonly	 seen	cause	 of	hyperbilirubinemia	in	the	
outpatient	settings	is	breastfeeding.	(Gardner	et	al.,	2016)		
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Figure	1.	Guideline	 for	phototherapy	use	for	infants	born	at	>35	
weeks	 gestation.	
Signs	and	symptoms	
• Initiate	breastfeeding	within	1	hour	of	delivery.
• Encourage	at	least	10	breastfeeds	in	24-hour	period.
• Teach	effective	breastfeeding	practices	to	ensure	
proper	nutrition	and	dehydration	prevention.
(Moncrieff,	 2018)
• Delay	discharge	from	hospital	until	effective	
breastfeeding	is	established.
• Educate	caregivers	on	signs	and	symptoms	of	rising	
serum	bilirubin	levels.
(Wells,	Ahmed,	&	Musser,	2013)	
• Infant	should	 be	observed	by	lactation-trained	
healthcare	provider	within	first	48-72	hours	post	
discharge	from	 hospital	(CDC,	2016).
• Encourage	physicians	 to	comply	with	protocols	to	
identify	hyperbilirubinemia	in	the	early	stages	(Wells	
et	al.,	2016).
• Monitor	patients	on	phototherapy.
• Once	 serum	bilirubin	levels	fall	below	the	hour-
specific	 value,	discontinue	phototherapy	and	check	
for	rebound	 hyperbilirubinemia	within	24	hours.		
(Gardner	et	al.,	2016)
Why	breastfeeding-associated	
hyperbilirubinemia?
• Commonly	 seen	in	outpatient	setting
• Adequate	identification	necessary	
• Timely	treatment	needed	to		prevent	extreme	
hyperbilirubinemia	leading	to	kernicterus	
(Moncrieff,	 2018)
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report/_jcr_content/par/featured_image/media-
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Pathophysiology
• 70-90	day	life	span	for	newborn	 red	blood	cells	(RBCs)	
• RBCs	 destroyed	by	macrophages	in	spleen
o Breakdown	into	globin	protein	and	heme
• Heme	turns	to	biliverdin	by	means	of	heme	oxygenase.
• Biliverdin	converts	to	unconjugated	bilirubin	by	the	
enzyme,	biliverdin	reductase.
• Unconjugated	 bilirubin	not	water	soluble,	must	bind	to	
protein	in	blood	(albumin).	
• Bilirubin	bound	 to	albumin	is	carried	to	liver	and	
disassociated	from	 albumin	 prior	to	entering	liver	cell.
• In	liver	cell,	unconjugated	bilirubin	becomes	
conjugated	bilirubin	by	enzyme	catabolism.
• Water	soluble	conjugated	bilirubin	which	enables	
bilirubin	to	be	secreted	in	bile.
• Bile	secreted	into	intestinal	tract	for	conjugated	
bilirubin	to	be	excreted	by	urine	and	stool.
(Gardner	et	al.,	2016)
What	physiological	process	 is	altered	
breastfeeding-associated	
hyperbilirubinemia?
Breastfeeding	failure	has	occurred
• Inadequate	supply,	inadequate	latch,	or	inadequate	
frequency	 leading	to:	
o Delayed	stooling	and	decreased	
gastrointestinal	motility
o Dehydration
o Poor	caloric	intake
o Greater	than	10%	weight	loss
• Increase	in	enterohepatic	circulation	and	decreased	
bile	removal	occur.
• Serum	bilirubin	levels	rise.	
(Gardner	et	al.,	2016)	
• Hyperbilirubinemia	diagnosis	when	total	serum	
bilirubin	levels	rise	above	the	95th percentile	for	age	
(Figure	1)	(Ullah,	Rahman,	&	 Hedayati,	2016).	
• Phototherapy	with	lights	of	the	blue-green	spectrum	
used.
• Phototherapy	converts	unconjugated	bilirubin	to	
conjugated	bilirubin	cutaneously enabling	excretion	
via	urine	and	stool.	
(Itoh	et	al.,	2017)	
• Most	notable	signs	and	symptoms	is	jaundice,	
specifically	of	 the	skin	and	sclera	(Stanford	Children’s	
Hospital,	2018).	
• Lethargy
• Poor	feeding
• High	pitch	cry
• Irritability
• Hypotonia
• Fever
• Apena
• Hypertonia
• Seizures	
(Centers	 for	Disease	Control	and	Prevention	[CDC],	2016)	
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Implications	 for	Nursing	Care
Conclusion	
Moncrieff	 (2018)	 states,	“Although	the	
yellow	pigmentation	changes	may	seem	
harmless,	extreme	hyperbilirubinemia	
can	lead	to	kernicterus,	an	irreversible	
and	devastating	brain	injury”.		
Kernicterus	is	preventable	with	
appropriate	interventions	and	treatment	
(Wells	et	al.,	2013).			Families	need	to	be	
educated	and	 aware	of	signs	and	
symptoms	 of	increasing	bilirubin	levels	
and	to	follow	up	with	clinicians	
appropriately.		It	is	imperative	that	
bilirubin	levels	are	monitored	
appropriately	and	early	intervention	is	
implemented	 to	prevent	long	
neurological	damage.	
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